Doxorubicin liposome Intravenous and Memantine Extended-Release Capsules
Determining the interaction of Doxorubicin liposome Intravenous and Memantine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: doxorubicin liposomal
Brand name: Doxil, Lipodox, Lipodox 50
Synonyms: Doxorubicin liposomal, DOXOrubicin (Liposomal)
Generic Name: memantine
Brand name: Namenda, Namenda XR
Synonyms: Memantine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Doxorubicin liposome Intravenous-Memantine Hydrochloride
- Doxorubicin liposome Intravenous-Memantine Oral Solution
- Doxorubicin liposome Intravenous-Memantine Solution
- Doxorubicin liposome Intravenous-Memantine Tablets
- Doxorubicin liposome Intravenous-Members Mark Cetirizine
- Doxorubicin liposome Intravenous-Members Mark Loratadine
- Memantine Extended-Release Capsules-Doxy 100
- Memantine Extended-Release Capsules-Doxycycline
- Memantine Extended-Release Capsules-Doxycycline Calcium
- Memantine Extended-Release Capsules-Doxycycline Capsules (Rosacea)
- Memantine Extended-Release Capsules-Doxycycline Capsules with Omega-3 and Vitamin E Capsules
- Memantine Extended-Release Capsules-Doxycycline Delayed Release Capsule